ArticleScience advances2020
Inhibition of the translesion synthesis polymerase REV1 exploits replication gaps as a cancer vulnerability.
Sumeet Nayak et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
86 papers cite itlatest 60 shown
this papercites it